GBT Announces Participation at Upcoming Investor Conferences in March

SOUTH SAN FRANCISCO, Calif., March 05, 2018 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT) today announced that it will present at the following investor conferences in March 2018:

• Cowen and Company 38th Annual Health Care Conference in Boston on March 12 at 11:20 a.m. Eastern Time (ET);
• 28th Annual Oppenheimer Healthcare Conference in New York City on March 20 at 10:55 a.m. ET; and
• 17th Annual Needham Healthcare Conference in New York City on March 27 at 11:30 a.m. ET.

The presentations will be webcast live and available for replay from GBT’s website at www.gbt.com in the Investors section.

About GBTGBT is a clinical-stage biopharmaceutical company determined to discover, develop and deliver innovative treatments that provide hope to underserved patient communities. GBT is developing its lead product candidate, voxelotor, as an oral, once-daily therapy for sickle cell disease. To learn more, please visit www.gbt.com and follow the company on Twitter @GBT_news.

Contact Information:Myesha Lacy (investors)GBT650-351-4730[email protected] 

Julie Normart (media)W2Opure415-946-1087[email protected]

Source: Global Blood Therapeutics, Inc.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Needham Starts Red Violet (RDVT) at Buy, 'offers the leading Cloud identity intelligence platform in the market today'
• IBA joins PFAROS European initiative to advance PFAS destruction for healthcare and pharmaceutical applications
• Momcozy Publishes Baby Carrier vs. Stroller Comparison Guide